Skip to main content

Closed

ANIK: Anika Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Medical - Devices

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-4.2%

ROIC-3.2%

Financially safe

Stretched

Debt / equity0.17×

Interest coverage0.0×

Current ratio4.48×

Anika Therapeutics, Inc.

ANIKNASDAQ Global Select·USD·Closed

Anika Therapeutics, Inc.

ANIKNASDAQ·USD·Closed

$19.28

+6.70%

$19.28

+$1.21 (6.70%)

52W Range

100thpctl

Volume

2.16×avg

Mkt Cap

258.02MUSD

P/E

-71.5TTM

Div Yield

–ann

52W Range

100thpctl

Volume

2.16×avg

Market Cap

258.02MUSD

P/E Ratio

-71.5TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings